NCT02184286View on ClinicalTrials.gov

Pharmacokinetic Interaction Between Nevirapine and Saquinavir-sgc in HIV-1 Infected Patients

PHASE1TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 31, 1999

Primary Completion Date

February 29, 2000

Conditions
HIV Infections
Interventions
DRUG

Nevirapine

200 mg q.d. days 1-14 followed by 200 mg b.i.d. days 15-28

DRUG

Saquinavir-sgc

1600 mg b.i.d. from pre trial to day 28

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02184286 - Pharmacokinetic Interaction Between Nevirapine and Saquinavir-sgc in HIV-1 Infected Patients | Biotech Hunter | Biotech Hunter